What is Excite Pharma Services?
Excite Pharma Services operates as a Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO), offering specialized pharmaceutical services. The company adheres to stringent FDA, cGMP, and GLP standards, catering to pharmaceutical firms in need of reliable manufacturing and chemistry expertise. Based in Lees Summit, Missouri, Excite Pharma is a key player in supporting drug development and production pipelines.
How much funding has Excite Pharma Services raised?
Excite Pharma Services has raised a total of $461K across 2 funding rounds:
Debt
$150K
Debt
$311K
Debt (2020): $150K with participation from PPP
Debt (2021): $311K led by PPP
Key Investors in Excite Pharma Services
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Excite Pharma Services?
The substantial late-stage funding indicates Excite Pharma Services is poised for significant scaling and operational expansion. This strategic investment will likely be directed towards enhancing manufacturing capabilities, expanding research and development services, and potentially broadening its market reach. The company's focus on compliance and quality positions it to capitalize on the growing demand for outsourced pharmaceutical services, driving innovation and efficiency in drug development.
See full Excite Pharma Services company page
